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www.carjonline.orgInvasive coronary angiography remains the gold standard
for imaging of the coronary arteries. Because of poor
temporal and spatial resolution, noninvasive imaging of the
heart using computed tomography (CT) had remained
a challenge until the recent past. Since 1999, and the advent
of 4-detector electrocardiogram (ECG)-gated CT, there have
been rapid technical developments in CT technology and
postprocessing tools, thus enabling an accurate noninvasive
assessment of cardiac anatomy including the coronary
arteries as well as cardiac function. Today, this relatively new
technique increasingly is being requested and performed on
a routine basis.
Although guidelines and standards for the performance of
cardiac CT (CCT) have been published by other societies
outside of Canada [1e5], the Canadian Association of
Radiologists recognizes that Canadian radiologists play
a leading and pivotal role in the safe and proper imple-
mentation of CCT throughout the country, as well as in the
training and continuing medical education of physicians
performing and interpreting CCT studies. This comprehen-
sive article reviews the current evidence for CCT to date and
outlines the standards for the implementation of a CCT
program. Based on the review of the current literature and on
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doi:10.1016/j.carj.2009.02.006expert opinion, recommendations regarding indications and
contraindications for CCT also are provided.
Methods
The CCT expert committee comprises radiologists with
cardiac expertise in each of the topic areas. Before comple-
tion, the standards and guidelines were distributed to the
Canadian Association of Radiologists executive committee
for the opportunity to provide feedback concerning the
recommendations. The literature will be reviewed periodi-
cally and the standards and guidelines will be updated as new
or compelling evidence is identified.
Literature Search Strategy
The literature was searched using MEDLINE (OVID:
1966 through October 2008), EMBASE OVID: (1988
through October 2008), and the Cochrane Library (OVID:
issue 3, 2008). Reference lists of related articles and recent
review articles also were scanned for additional citations.
Study Selection Criteria
Given the nature of the topic, it was widely accepted
among the CCT Writing Group that the strength of the
evidence from the published literature would vary consider-
ably, and in many cases would not be sufficient to inform
recommendations on the topic. In the event of limited data, its. Published by Elsevier Inc.
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recommendations. As such, only the highest levels of evidence
were considered such as systematic reviews, randomized
controlled trials, meta-analyses, nonrandomized comparative
studies, prospective single-cohort studies, and, finally, retro-
spective single-cohort studies. Articles were excluded from
the systematic review of the evidence if they were reported
in a language other than English or involved pediatric
populations.
Results
Review of CCT Evidence
Calcium score
Coronary artery calcium (CAC) is a general surrogate for
total atheroma burden [6]. Most of the studies that have
addressed CAC have been based on results from electron-
beam CT systems, which are largely no longer available.
These systems have been replaced by multidetector CT
(MDCT). Early studies have shown similar CAC scores can
be obtained with these systems [7e9].
Outcome studies have shown that CAC scores add
incremental prognostic value to the evaluation of asymp-
tomatic patients at intermediate risk (10-year risk, 10%e
20%) for a coronary event [10e15] in Caucasians using the
Framingham risk score [16], the PROCAM score [17], or the
European SCORE system [18]. The value of CAC scoring in
asymptomatic patients at low risk or high risk of a coronary
event is controversial [5,19]. There still are limited data
concerning the predictive value of CAC in non-Caucasians.
CAC is not an indicator of significant coronary artery
stenosis. Investigators have concluded that although CAC
scores are highly sensitive, they are only moderately specific
for the detection of a coronary artery stenosis greater than
50% [20].
A zero calcium score is associated with a very low event
rate in most risk categories and is associated with a very low
prevalence of ischemia on functional testing and significant
coronary stenosis on invasive angiography [5,21].
There is significant variability in CAC scores on MDCT
on sequential examinations [22,23].
Coronary Artery Imaging
Detection of coronary artery stenosis
Four- and 16-detector CT. Noninvasive CT imaging of the
coronary arteries (CCTA) requires high temporal and spatial
resolution and became possible with the development of
MDCT technology.
The first generation of MDCT scanners were 4-slice
systems. They were limited by long scan times, and lacked
the temporal and spatial resolution of subsequent generations
of scanners. The coronary arteries could be imaged but
assessment was restricted to the proximal vessels and up to25% of coronary segments were uninterpretable because of
poor image quality [24,25].
The subsequent 16-slice scanners had improved temporal
and spatial resolution and acquired data in a shorter breath-
hold, resulting in improved imaging of the coronary tree. A
recent meta-analysis of articles comparing cardiac CTA
(CCTA) with conventional coronary angiography for the
detection of coronary stenoses greater than 50% showed the
following figures for 16-detector CT [26]. Per coronary
segment analysis: sensitivity, 77%; specificity, 91%; positive
predictive value, 60%; and negative predictive value, 96%.
Per patient analysis: sensitivity, 95%; specificity, 69%;
positive predictive value, 79%; and negative predictive value,
92%.
Despite the technical improvements with 16-detector CT,
4.4% of patients have nonevaluable scans and up to 29%
(mean, 10%) of coronary segments remain unassessable [26].
Exclusion of these unassessable patients and segments from
analysis in many articles gives a false impression of the
diagnostic performance of MDCT and the earlier-described
figures must be interpreted with this in mind.
Sixty-fouredetector CT. At the time of this writing, the
current generation of MDCT scanners are 64-detector tech-
nology. Having further improvements in spatial and temporal
resolution and a shorter scan time, 64-detector CCTA allows
significantly improved diagnostic performance over 16-
detector technology [26e28]. Since the first publication on
64-detector CCTA in April 2005, [28] there has been
a plethora of studies comparing 64-detector CCTA with
conventional coronary angiography [29e41]. Five meta-
analyses published over the past 2 years have had differing
inclusion/exclusion criteria but confirm similar results,
summarized in Tables 1 and 2 [26,27,42e44].
Per-segment sensitivity is 88% to 93%, specificity is 96%
to 97%, positive predictive value is 73% to 79%, and nega-
tive predictive value is 96% to 99%. Per-patient sensitivity is
97% to 99%, specificity is 88% to 93%, positive predictive
value is 93% to 94%, and negative predictive value is 95% to
100%. Nonevaluable scans occurred in 1.9% of patients and
the 4% of segments were unevaluable [26].
The major advancements with 64-detector CCTA are
a reduction in unevaluable scans and unevaluable vessel
segments, and a considerable improvement in per-patient
specificity and positive predictive value. Negative predictive
Table 1
Sixty-fouredetector CCTA meta-analyses: per coronary segment analysis
Sensitivity, % Specificity, % PPV, % NPV, %
Vanhoenacker et al [27] 93 96 N/A N/A
Hamon et al [26] 88 96 79 98
Sun et al [42] 90 96 75 98
Mowatt et al [43] 90 97 76 99
Stein et al [44] 90 96 73 96
N/A ¼ not applicable; NPV ¼ negative predictive value; PPV ¼ positive
predictive value.
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per-patient and per-segment analyses.
Beyond current 64-detector technology. At the time of this
writing, a new generation of CT scanners are being released.
Equipment manufacturers are taking diverse paths with
regards to advancing the technology. It is likely that these
advancements will improve on the current 64-detector tech-
nology. There is insufficient literature concerning these new
technologies to be included in this article.
Disease Prevalence and Pretest Cardiovascular Risk
The vast majority of studies included in the available
meta-analyses are in patient groups with a high prevalence of
coronary artery disease (mean prevalence of coronary
disease, 59% [26], 53% [42], and 61% [44]). Disease prev-
alence has a bearing on the negative and positive predictive
values of an investigation. High disease prevalence results in
higher positive predictive values and lower negative predic-
tive values, low prevalence results in lower positive predic-
tive values and higher negative predictive values [45,46].
Furthermore, although Bayesian theory dictates that the
sensitivity or specificity of an investigation is not affected by
disease prevalence, they are influenced by the composition of
the population on which an investigation is assessed [47,48].
In the context of CCTA, in a population with a low or
intermediate likelihood of coronary disease, not only is the
prevalence of coronary disease low, but it is to be expected
that the severity of the disease will be less than in a high-risk
group, with different lesion composition and disease distri-
bution within the coronary tree. The sensitivity and speci-
ficity of CCTA in the low- and intermediate-risk groups
therefore may be different from that in the published meta-
analyses.
Two studies have assessed the performance of CCTA in
different patient groups. Husmann et al [48] stratified 88
patients into high-, intermediate-, and low-risk groups
according to Framingham 10-year risk. Meijboom et al [49]
stratified 254 patients into high-, intermediate-, and low-risk
groups according to the Duke Clinical Score. Both studies
found similar results. Specificity was lower in the high-risk
group. Positive predictive value was lower in the low-risk
group. Negative predictive value was high across all groups
in per-patient and per-segment analyses. The implication of
these findings is that in low- and intermediate-risk groups,
CCTA can exclude disease reliably, but there will be an
Table 2
Sixty-fouredetector CCTA meta-analyses: per-patient analysis
Sensitivity, % Specificity, % PPV, % NPV, %
Vanhoenacker et al [27] 99 93 N/A N/A
Hamon et al [26] 97 90 93 96
Sun et al [42] 97 88 94 95
Mowatt et al [43] 99 89 93 100
Stein et al [44] 98 88 93 96
N/A ¼ not applicable; NPV ¼ negative predictive value; PPV ¼ positive
predictive value.increasing number of false-positive cases as pretest risk
decreases.
Patient Parameters Influencing CCTA Diagnostic
Performance
Certain patient parameters have been shown to affect the
diagnostic performance of 64-slice CCTA adversely: coro-
nary calcification, high heart rate, heart rate variability, and
body mass index.
Higher levels of coronary calcification are associated with
poorer 64-detector CCTA diagnostic performance, with
various investigators showing an increased number of unas-
sessable segments, lower specificity, lower positive predic-
tive value, and poorer image quality [32,33,50e52]. The
widely accepted explanation for this is that calcification
causes blooming artifact and beam-hardening artifact, which
lead to an overestimation of the degree of stenosis. This
effect is more pronounced when calcification is denser,
however, there is great heterogeneity among the studies in
determining high- and low-calcification categories and there
is no consensus as to an unacceptably high level for the
performance of CCTA.
High heart rates are associated with poorer diagnostic
performance of 64-detector CCTA [33,51e55] as a result of
motion artifact. In the majority of published articles, b-
blocking medication was used to limit the heart rate. It
should be noted that the target heart rate was variable (most
commonly <65 bpm) and not always achieved, but that in
general, image quality improves as the heart rate is lower.
Variability of heart rate is associated with poorer diag-
nostic performance [55,56] as well, owing to data misregis-
tration artifact between heart beats. b-blockade is beneficial
in reducing heart rate variability [55].
Obesity causes increased image noise, which reduces
contrast resolution of the coronary arteries [51]. Raff et al [33]
reported decreased sensitivity, specificity, positive predictive
value, and negative predictive value in 64-detector CCTA in
patients with a body mass index greater than 30 kg/m2.
Multicentre Evidence
The vast body of evidence on the performance of 64-
detector CCTA is based on single-centre academic unit
publications. Ong et al [41] reported findings from a centre
with no prior experience in CCTA and showed very high
negative predictive values but poorer per-patient sensitivity
and positive predictive values, and a higher percentage of
unevaluable segments than those published by more expe-
rienced centres. They concluded that inexperienced centres
may not be able to replicate the published experienced
centre results.
At the time of this writing, the ACCURACY trial [52] is
the only published multicentre trial assessing the perfor-
mance of 64-detector CCTA. A total of 240 low- to inter-
mediate-risk patients were recruited and had 64-detector CT
and coronary angiography performed at 16 different centres,
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demic centres. CCTA studies were not read at the recruiting
centre, but were read by 2 of 3 investigators, one of whom
was from a nonacademic centre. Per-patient analysis for
coronary artery stenoses of 50% or greater showed a sensi-
tivity of 95%, a specificity of 83%, a positive predictive value
of 64%, and a negative predictive value of 99%. Similar to all
the published single-centre trials, negative predictive value
was high, however, sensitivity was slightly lower and positive
predictive value was considerably lower. Whether this is
because of the multicentre nature of the study or the relatively
low prevalence of disease in the study population (25%) is
unclear, however, the positive predictive value is similar to
that reported in studies assessing the performance of 64-
detector CCTA in high- versus low-risk populations [48,49].
Summary
1. Sixty-fouredetector CCTA outperforms 16-detector
CCTA, which in turn outperforms 4-detector CCTA. The
major difference is in the number of unassessable studies
and unassessable vessel segments.
2. Sixty-fouredetector CCTA detects coronary stenoses of
50% or greater with a high sensitivity and high negative
predictive value.
3. Positive predictive value is lower in populations with low
disease prevalence.
4. Coronary calcification, high heart rate, variable heart
rate, and obesity have a negative impact on the diag-
nostic performance of 64-detector CCTA.
5. Results of inexperienced centres may not replicate those
published by experienced academic centres.
Functional Relevance, Lesion Quantification, and
Characterization
It should be recognized that CCTA assesses the anatomy of
the coronary tree and does not provide information as to the
functional relevance of stenoses. Comparison of conventional
coronary angiography with stress-perfusion positron emission
tomography has shown that the vasodilator reserve (the ability
to increase flow from baseline resting state) declines incre-
mentally between 40% diameter stenosis up to 80% diameter
stenosis [57]. Almost all of the studies of 64-detector CCTA
have used the figure of 50% to represent a significant stenosis.
When the functional relevance of these significant stenoses is
assessed, a large proportion is found not to be associated with
stress-induced ischemia. Meijboom et al [58] found only 18%
of CCTA stenoses of 50% or greater to have a fractional flow
reserve of less than 0.75, the level indicative of stress-induced
ischemia. In comparing 64-slice CCTA with single photon
emission CT myocardial perfusion imaging, Gaemperli
et al [59] showed a CCTA stenosis of 50% or greater to have
only a 58% positive predictive value of positive myocardial
perfusion imaging, Schuijf et al [60] showed only 39% of
patients with stenosis of 50% or greater to have abnormal
myocardial perfusion imaging, and Scholte et al [61] showed67% of patients with stenosis of 50% or greater to have
abnormal myocardial perfusion imaging.
A small number of studies have compared 64-slice CCTA
with conventional angiography for detection of stenoses
greater than 50%. Herzog et al [62] reported similar sensi-
tivity, specificity, positive predictive value, and negative
predictive value for 50% and 70% lesions, with a negative
predictive value of 100% for patient-based analysis. Budoff
et al [52] also reported very similar sensitivity, specificity,
and negative predictive value (99%) for 50% and 70%
stenoses, however, positive predictive value was lower for
70% lesions. Muhlenbruch et al [39] reported only on 70%
lesions and showed a sensitivity of 98%, a specificity of 50%,
a positive predictive value of 94%, and a negative predictive
value of 75%. In this study, prevalence of disease was 90%,
which may explain the low negative predictive value and low
specificity. Studies comparing 64-slice CCTA with conven-
tional angiography that have categorized lesions further into
quartile or smaller ranges of stenoses have shown a tendency
for CTA to overestimate the degree of stenosis [63e65]. Raff
et al [33] determined that although the mean difference
between CCTA and conventional angiography grading of
stenoses was small (1.3%), the standard deviation of differ-
ences was such that in only approximately 90% of cases, the
CCTA grading was within  one quartile grading of the
conventional angiogram.
Intravascular ultrasound (IVUS) is used commonly in the
catheterization laboratory to give more anatomic information
and more accurate quantification of stenotic coronary pla-
ques [66]. Similar to IVUS, CCTA shows not only the vessel
lumen but also plaque and vessel wall. Several investigators
have compared 64-detector CCTA with IVUS for the detec-
tion and quantification of disease. Sun et al [67] reported
excellent results for the detection of plaque in a population
with suspected coronary disease (sensitivity, 97%; speci-
ficity, 90%; positive predictive value, 90%; and negative
predictive value, 97%). In a population with less disease,
Gregory et al [68] reported poorer results for plaque detec-
tion (sensitivity, 70%; specificity, 92%; positive predictive
value, 89%; and negative predictive value, 77%). Several
investigators reported reasonable correlation between CCTA
and IVUS for lesion quantification. For percentage area of
stenosis Sato et al [69] reported a correlation coefficient of
0.87 and Leber et al [30] reported a correlation coefficient of
0.61. Both commented that CCTA tends to underestimate the
percentage of stenosis owing to an overestimate of the lumen
size. Caussin et al [70] reported a correlation coefficient of
0.88 for the assessment of mean luminal area. For the
assessment of lesion plaque volume Leber et al [71] reported
a correlation coefficient of 0.69 and Otsuka et al [72]
reported a correlation coefficient of 0.98. In all of these
studies, selected arteries or segments were used for the IVUS
study and by the nature of the IVUS procedure, these
assessments generally were made on larger proximal vessels.
Plaque characterization is an area of great interest. Several
studies have reported 64-slice CCTA demonstration of
certain characteristics that are more common in culprit
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Sixty-fouredetector CCTA studies of coronary in-stent stenosis (per stent analysis)
Stents Excluded Stenoses Sensitivity Specificity PPV NPV
Hecht et al [81] 132 0 17 94 74 39 99
Carrabba et al [82] 87 0 13 84 97 92 97
Carbone et al [83] 88 21 16 75 86 71 89
Das et al [84] 110 13 32 97 88 78 91
Schuijf et al [85] 76 11 6 100 100 100 100
Oncel et al [86] 39 0 19 89 95 94 90
Rixe et al [87] 102 43 12 88 98 86 98
Cademartiri et al [88] 192 14 20 95 93 63 99
Ehara et al [89] 125 15 24 91 93 77 98
Rist et al [90] 46 1 8 75 89 67 94
NPV ¼ negative predictive value; PPV ¼ positive predictive value.lesions in patients with acute coronary syndrome such as
positive remodelling, low attenuation plaque, spotty calcifi-
cations, and ring-like foci [73e77]. Results for character-
ization of plaque composition, however, are disappointing in
that although CCTA is excellent at differentiating calcified
and noncalcified plaque, differentiation between the different
components of noncalcified plaque (fibrous, fibrofatty,
necrotic) is poor [67,78].
Summary
1. A significant percentage of coronary stenoses of 50% or
greater are not associated with ischemia.
2. There are little data regarding CCTA versus conventional
angiographic quantification of lesions other than binary
quantification around 50% stenosis. The data available
indicate that there is considerable variability in quanti-
fication, however, the tendency is for CCTA to over-
estimate lesions. Systematic overestimation of the degree
of stenosis would maintain a high sensitivity and nega-
tive predictive value at the expense of specificity and
positive predictive value.
3. On the basis of limited data, CCTA compares favourably
with IVUS for detection of plaque in a population with
high disease prevalence, but compares less favourably
when disease is less prevalent.
4. CCTA quantification of disease compares favourably
with IVUS but tends to underestimate the degree of
stenosis.
5. CCTA performs well in the differentiation of calcified
and noncalcified plaques, but poorly between different
types of noncalcified plaques.
Assessment of Coronary Stents
Early evidence for 64-detector CCTA visualization of
coronary stents was discouraging. Maintz et al [79] assessed
the lumen visibility of 68 different coronary stents in an ex
vivo static model and reported only 10 of the stents to allow
greater than 66% lumen visibility. Stent diameters ranged
from 2.5 to 4 mm (majority, 3 mm). In vivo, Sheth et al [80]
reported 56% of 54 stents scanned within 48 hours of
deployment to be unassessable owing to artifact.Despite these shortcomings, a number of investigators
subsequently have shown 64-detector CCTA to have
a reasonably high negative predictive value for detection of
in-stent stenosis ranging from 89% to 100% (Table 3) [81e
90]. The literature shows a reasonably high but variable
sensitivity (75%e100%) and specificity (74%e100%) and
a wide range of positive predictive values (39%e100%). Also
variable was the percentage of stents regarded as unassessable
(range, 0%e42%). Pooled data from these studies showed
11.8% of stents to be unassessable and to have been excluded
from analysis. The results are summarized in Table 3. Factors
influencing lumen visibility and stent assessability were stent
diameter, stent material, stent strut size and density, over-
lapping stents, heart rate, and body mass index [79,85,87,91,92].
In particular, assessability was poor for stents of 3 mm or less in
diameter [80,83,87].
Summary
1. A significant percentage of coronary stents prove to be
unassessable by 64-detector CCTA.
2. Adverse features for stent assessment are small size (<3
mm), dense stents with large struts, overlapping stents, high
heart rate, heart rate variability, and high body mass index.
3. Excluding unassessable stents, 64-detector CCTA has
a high negative predictive value for detection of in-stent
stenosis of 50% or greater.
Assessment of Coronary Artery Bypass Grafts
Coronary artery bypass grafts are less mobile, contain less
calcification, and in the case of vein grafts are larger than the
coronary arteries and so should be well suited for assessment
with 64-detector CCTA. Multiple investigators have
addressed this and have reported similar results, despite
differences in graft types (arterial or venous) and different
study exclusion criteria with regards to high heart rate or
arrythmia [93e100]. The results are summarized in Table 4.
Similar to CCTA of the native coronary arteries, CCTA of
coronary artery bypass grafts has extremely high sensitivity
and negative predictive value, close to 100%. Specificity and
positive predictive value are also very high, but slightly less
impressive. In all studies differentiating occlusion from
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Sixty-fouredetector CCTA studies of coronary artery bypass graft stenosis (per-graft analysis for combined stenosis of 50% or greater and occlusion)
Grafts (A/V) Unassessable Stenoses Sensitivity Specificity PPV NPV
Malagutti et al [93] 109 (45/64) 0 49 100 98 98 100
Pache et al [94] 96 (23/73) 3 45 98 89 90 98
Dikkers et al [95] 69 (52/17) 4 17 100 99 94 100
Ropers et al [96] 138 (37/101) 0 54 100 94 92 100
Meyer et al [97] 406 (147/259) 9 116 97 97 93 99
Jabara et al [98] 147 (47/100) 20 42 95 100 100 98
Onuma et al [99] 146 (74/72) 8 10 97 98 94 99
Feuchtner et al [100] 70 (46/24) 0 14 85 95 80 96
A/V ¼ arterial/venous; NPV ¼ negative predictive value; PPV ¼ positive predictive value.data set, CCTA is very well suited to detect and define the
anatomic course of coronary artery anomalies and their
relationship to other cardiac and noncardiac structures. A
number of case reports and several research reports [104e
107] have shown that the CCTA analysis of coronary anatomy
in these patients is straightforward and very reliable, with




By using advanced postprocessing methods, left ventricular
functional parameters such as end-diastolic and end-systolic
volumes, stroke volume, ejection fraction, myocardial mass,
and regional wall motion abnormalities can be assessed and
have shown good agreement with echocardiography, mono-
plane and biplane ventriculography, and gated single photon
emission CT as well as magnetic resonance imaging (MRI)
[108e120]. A recent meta-analysis of MDCT left ventricular
function analysis compared with MRI in 252 patients showed
a weighted average difference of -1.7%  3.1%, a difference
that is not relevant in clinical practice [121].
Right ventricular function
There are limited data on the accuracy of MDCT in
assessing right ventricular function. Right ventricular (RV)
quantification requires optimized contrast opacification of the
right ventricle. Small studies, mostly using 16-detector CT,
have shown good correlation of RV ejection fraction, RV end-
diastolic volume, RV end-systolic volume, and stroke volume
with radionuclide ventriculography, MRI, cardiac catheteri-
zation, and echocardiography in patients suspected of
coronary artery disease, [116,122,123] suspected RV
dysfunction [124,125], suspected pulmonary emboli [126,127],
and congenital heart disease [128].
Valvular Function
The assessment of aortic stenosis has been the subject of
several studies using 16-, 40-, and 64-detector CT. Aortic valve
area using planimetry has been compared with transthoracic
echocardiography (TTE) using the Doppler continuity equa-
tion, cine MR planimetry, and transesophageal echo planimetrystenosis, performance was better for occlusion than for
stenosis. The small numbers of errors (nearly all false posi-
tives) and unassessable grafts were caused almost exclusively
by metallic clips adjacent to the graft, most often at the distal
anastomosis, and these were more common in arterial grafts.
The size of the graft target vessel, [100] heart rate, and
arrythmia [97] are other factors that influence diagnostic
accuracy. In 2 of the studies, grafts were depicted at CCTA
that were not visualized at conventional angiography.
In clinical practice the status of the native nongrafted coro-
naries and the grafted run-off vessels is essential information for
decisions on revascularization. In this patient group, the native
coronaries, and in particular the graft run-off vessels, have
a higher likelihood of being small, diseased, and calcified and so
are relatively unfavourable for CCTA assessment. This is
confirmed by those studies reporting assessment of the native
coronary arteries and run-off vessels showing significantly
poorer performance than the body of literature for assessment of
coronary disease in nongrafted patients [93,95,96,99].
Summary
1. Sixty-fouredetector CCTA has excellent negative
predictive value and very good positive predictive value
for detection of coronary artery bypass graft stenosis of
50% or greater.
2. A small percentage of grafts are unassessable by 64-
detector CCTA.
3. Adverse features for graft assessment are adjacent
metallic clips, arterial grafts, small target vessels, high
heart rate, and heart rate variability.
4. Sixty-fouredetector CCTA determination of the status of
the run-off vessels and native coronary arteries is rela-
tively poor.
Imaging of Coronary Anomalies
Although coronary anomalies are relatively rare condi-
tions, a small proportion have the potential to cause ischemia,
myocardial infarction, and sudden death [101]. In young
athletes, coronary artery anomalies are the second most
common cause of sudden death as a result of structural heart
disease [102]. The identification of the origin and course of
aberrant coronary arteries by conventional angiography can
be difficult [103]. Because of the 3-dimensional nature of the
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good correlation between CT and the other modalities
(r ¼ 0.76e0.99) [92,129e134]. Some investigators found
a slight systematic overestimation of aortic valve area compared
with TTE [132,133]. Only 2 investigators evaluated the sensi-
tivity and specificity of 64-detector CT in the detection of aortic
stenosis with sensitivities ranging between 82% and 100% and
specificities ranging between 77% and 93.7% [129,133]. In his
study of 52 patients with aortic stenosis evaluated with 64-
detector CT, Habis [133] also found good interobserver agree-
ment (difference, 0.002; variability, 0.112 cm2).
Fewer data exist concerning the use of CT in the evalu-
ation of aortic regurgitation. All studies showed good
correlation of aortic regurgitant area with the severity of
aortic valve regurgitation on TTE (r ¼ 0.75e0.86) [135e
137]. Feuchtner [135] found good interobserver agreement (r
¼ 0.97) for the determination of the aortic regurgitant area.
However, both Feuchtner et al [135] and Jassal et al [136]
found a low negative predictive value, especially in patients
with mild aortic regurgitation, possibly owing to artifact
caused by the presence of aortic valve calcification.
Finally, with regards to mitral valvular disease, only one
study could be found comparing 16-detector CTwith TEE and
catheter ventriculography in 19 patients with mitral regurgi-
tation. CT planimetry of the mitral valve regurgitant orifice
correlated significantly with the other modalities [138].
Myocardial Perfusion and Viability
Although the pharmacokinetics of CT contrast agents will
allow first-pass perfusion imaging, and assessment of
delayed enhancement for myocardial viability, only prelim-
inary studies are available showing good agreement with MR
[109,139e146]. The radiation dose required to perform these
studies remains a concern.
Left Atrium and Pulmonary Vein Assessment
It has been shown that the pulmonary veins are the source
of triggers initiating atrial fibrillation in 90% to 96% of
patients and that these foci can be eliminated effectively
using catheter ablation [147]. Success rates in patients
without underlying structural heart disease are greater than
80% [148]. Different ablation techniques include ostial
segmental isolation of the pulmonary vein [149] and
anatomically based circumferential ablation [150]. Pre-
procedural knowledge of the left atrial and pulmonary vein
anatomy is crucial for the electrophysiologist and this can be
provided with multidetector CT. Four-detector and higher
scanners can characterize posterior left atrial and pulmonary
vein anatomy accurately without and with ECG gating [151].
Sixteen- and 64-detector CT offer the advantage of decreased
scan time, decreased cardiac motion, and isotropic data sets,
which improve image quality even without gating. Important
information concerning the number, size, distance from the
ostium to the first branch, and the presence of anatomic
variants of pulmonary veins are important to help select thesize of the ablation catheters used to perform the procedure.
The dimensions of the left atrium, the presence of left atrial
appendage thrombus, and the anatomic course of the
esophagus relative to the posterior left atrial wall and
pulmonary veins also can be assessed [152,153].
Image integration systems for catheter ablation procedures
now are being used. With this technology, the 3-dimensional
CT reconstructions are merged with the electroanatomic
mapping data at the time of the procedure, with an accuracy
of 2-mm distance between corresponding points on the 2
images [154]. Some investigators have found an increased
success rate for catheter ablation using this technique
[155,156]. Kistler et al [155] also found a decrease in fluo-
roscopy time.
Finally, MDCT has proven to be useful in the follow-up
evaluation of patients after ablation therapy to assess for the
development of complications, especially to monitor the
development of pulmonary vein stenosis [157,158].
Coronary Vein Anatomy
In cardiac resynchronization therapy, left ventricular (LV)
pacing is achieved by positioning the LV lead in one of the
tributaries of the coronary sinus. Although the success rate
for transvenous LV lead placement is relatively high, in 5%
to 12% of patients the procedure does not succeed, [159] and
these numbers may be even higher in inexperienced centres.
Failure of LV lead placement has been attributed to the
inability to insert catheters in the coronary sinus and the lack
of suitable side branches [159,160]. Knowledge of the
cardiac venous anatomy before these procedures may facil-
itate LV lead positioning. In 2005, Jongbloed [161] et al
showed that noninvasive visualization of the coronary venous
anatomy was feasible with 16-detector CT and Van de Veire
et al [162] showed that visualization of the major tributaries
of the coronary sinus was comparable between invasive
venography and MDCT venography. He also suggested that
an additional 2-second delay should be applied after the
contrast bolus reached the descending aorta before triggering
the scan would optimize the scan for venous visualization.
Congenital Heart Disease
The population of adults with congenital heart disease is
increasing rapidly as a result of improved outcomes of surgical
and catheter-based treatment strategies. The most obvious and
clear indication for CCTA selection over MR
in imaging these patients is the presence of a permanent
implanted pacemaker or automated implantable cardiac defi-
brillator. CCT should act to augment the data collected using
echocardiography, particularly when there are limitations to
the echocardiographic examination owing to poor acoustic
windows in the setting of prior cardiac surgery or chest wall
deformity [163]. CT also supplements echocardiography data
in areas of echocardiographic weakness, particularly in the
evaluation of the aortic arch, coronary arteries, branch
pulmonary arteries, and collateral vessels. The decision to use
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[164]. CT strengths in congenital heart disease include but are
not limited to its fast acquisition time, limiting the need for
sedation. Its inherent high-spatial resolution offers evaluation
of cardiac chamber size, conduits, baffles, aortic arch, great
vessels, and pulmonary arteries and veins [165].
Pericardial Disease and Cardiac Masses
Echocardiography is the modality of choice in the initial
investigation of pericardial disease and cardiac masses. It
provides high-resolution, real-time images with recently
improved tissue characterization using tissue harmonics and
contrast echo [166]. However, because of restricted imaging
windows and limited tissue characterization, CT and MR
play an important role in the evaluation of pericardial
thickening and cardiac masses. CT is superior to MR in the
detection of calcification and to evaluate the extracardiac
extent of disease such as involvement of the lungs. CT also is
faster and less operator dependent than either echo or MR.
MR has much better soft-tissue contrast and enhancement
characteristics of masses can be assessed without the use of
ionizing radiation. In addition, the physiologic effects of
pericardial abnormalities on the cardiac chambers are better
characterized with MR as compared with CT because of its
higher temporal resolution [167e169].
Extracardiac Findings
As compared with echocardiography, nuclear imaging,
and conventional coronary angiography, CCT is unique in its
ability to image not only the heart, but also the surrounding
mediastinum, pulmonary vasculature, lungs, chest wall, and
upper abdomen. Extracardiac findings are found quite
commonly on CCT examinations. Multiple investigators have
reported on the incidence and significance of these findings
on cardiac CTA and electron-beam CT for calcium scoring.
Although the definition of significant findings varied between
studies, 4.2% to 22.7% of patients were reported to have
findings that required additional investigations or immediate
intervention [170e178]. Haller et al [172] showed that only
35.5% of the total chest volume was displayed on dedicated
coronary artery MDCT focused on the heart, whereas 70.3%
of the chest was visible when coronary artery MDCT raw
data were reconstructed with the maximal field of view.
Discussion
Based on the literature review and consensus expert
opinion, guidelines and standards for the performance of
CCT are provided later.
Guidelines for the Performance of CCT
Calcium score
The Writing Group supports the use of calcium scoring in
asymptomatic patients with an intermediate risk ofcardiovascular events using a traditional scoring system
because this may influence the decision to intensify risk
factor modification.
The Writing Group does not support calcium scoring in
the following situations: (1) in asymptomatic patients at low
or high risk for cardiovascular events, or (2) to monitor CAC
progression over time.
Coronary artery imaging
Coronary CTA should be performed only in centres with
adequate equipment by adequately trained staff. Studies must
be supervised and interpreted by adequately trained physicians
(see Standards for the Performance of Cardiac CT section).
Studies should be performed only on patients in whom
a diagnostic quality study is likely to be obtained and in whom
the result of the study will influence patient management.
Coronary Artery Evaluation: Clinically Stable Patients
The Writing Group supports the use of coronary CTA in:
1. Symptomatic patients with low to intermediate pretest
probability of obstructive coronary artery disease who
otherwise would be considered for conventional coronary
angiography. This typically would be patients with chest
pain and an equivocal or uninterpretable stress test.
2. Patients at low to intermediate risk of coronary artery
disease with planned surgery for valvular or structural
heart disease who otherwise would require preoperative
conventional coronary angiography.
The Writing Group does not support the use of coronary
CTA in:
1. Symptomatic patients with high pretest probability of
obstructive coronary artery disease or previously docu-
mented coronary artery disease.
2. Asymptomatic patients. It should be emphasized that there
currently is no evidence to support the use of coronary CTA
as a screening examination for coronary artery disease.
Coronary Artery Evaluation: Clinically Unstable
Patients
The use of coronary CTA in acute chest pain is controversial.
The high negative predictive value of coronary CTA is a valu-
able tool, but the relatively poorer positive predictive value,
particularly in populations with a low disease prevalence, is
a potentially problematic source of false-positive studies.
Furthermore, there is relatively poor correlation between CTA-
detected obstructive lesions and myocardial ischemia. There-
fore, positive studies require further assessment with either
stress testing and/or conventional coronary angiography.
The Writing Group advocates the use of coronary CTA in
patients with acute chest pain only in collaboration with
experienced clinicians for patients with low to intermediate
pretest probability of coronary artery disease.
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CTA in patients with acute chest pain who have either a high
pretest probability of obstructive coronary artery disease or
ECG or cardiac enzyme evidence of acute coronary syndrome.
Coronary Stent Evaluation
The Writing Group does not support the routine use of
coronary CTA for the evaluation of coronary artery stent
patency.
The Writing Group supports the use of coronary CTA for
the evaluation of coronary stent patency only in collaboration
with experienced physicians in select cases with low to
intermediate probability of stent stenosis who otherwise
would have conventional coronary angiography. Stents
should have a diameter greater than 3 mm. It is advised that
all unassessable and positive cases have conventional
angiographic confirmation of stent status.
Coronary Artery Bypass Graft Evaluation
The Writing Group supports the use of coronary CTA for
coronary artery bypass graft evaluation only in collaboration with
experienced clinicians in patients in whom the clinical question is
restricted to graft patency. The relatively poor performance for
assessment of run-off vessels in these patients is likely to impede
management decisions regarding revascularisation.
Coronary Artery Anomaly Evaluation
The Writing Group supports the use of coronary CTA for
the evaluation of suspected clinically relevant coronary
anomalies.
Noncoronary cardiac imaging
Ventricular function. The Writing Group supports the use of
CCT in the assessment of ventricular function when
(1) a retrospectively gated examination is obtained for other
accepted clinical indications, or (2) if this information cannot
be obtained through the use of other imaging modalities that
do not require the use of ionizing radiation such as echo-
cardiography or MRI.
Valvular function. The Writing Group supports the use of
CCT in the assessment of valvular function when
(1) a retrospectively gated examination is obtained for other
accepted clinical indications, or (2) if this information cannot
be obtained through the use of other imaging modalities that
do not require the use of ionizing radiation such as echo-
cardiography or MRI.
Myocardial Perfusion and Viability
Because of the limited data to date, the Writing Group does
not support the routine use of CT for assessing myocardial
perfusion and viability unless this is part of a research study.Left Atrium and Pulmonary Vein Assessment
The Writing Group supports the use of either gated or
ungated CCT for the assessment of the left atrium and
pulmonary veins (1) before atrial fibrillation ablation, and
(2) to assess suspected postprocedural complications.
Coronary Vein Anatomy
The Working Group supports the use of CCT for the
preprocedural assessment of the coronary veins in consulta-
tion with an electrophysiologist to answer a specific question
that will affect the management of an individual patient.
Congenital Heart Disease
The Writing Group advocates a team approach of
specialists with interest and knowledge in pediatric and adult
congenital heart disease, including clinical and interventional
cardiologists, radiologists, and echocardiographers. As with
any new technology and diagnostic technique several ques-
tions should be asked before selection of CT as the imaging
test of choice over more well-established techniques such as
MRI and echo.
1. Does CCT have the ability to answer the clinical question?
2. Will the results affect clinical management to justify the
ionizing radiation exposure?
3. Can another test without ionizing radiation answer the
clinical question without greater difficulty?
4. Is ECG gating necessary and, if so, can dose-reduction strat-
egies such as prospective gating be used to lower exposure?
Although there are no established criteria for patient
selection, the Writing Group advocates a balanced and
thoughtful approach to CCT in congenital heart disease as
outlined earlier.
Pericardial Disease and Cardiac Masses
The Writing Group supports the use of CCT in the
investigation of pericardial disease or cardiac masses when:
1. The findings on echo or MRI are inconclusive.
2. There is a contraindication to MRI such as the presence
of a pacemaker, claustrophobia, or the inability to
tolerate the examination.
3. CT is required to complete the staging of a probable
cardiac malignancy.
Extracardiac Findings
Investigators have determined that only one third of the
total chest volume is displayed on the coned down field of
view images of a CCT, but the relatively high radiation dose
acquisition contains information on the entire thorax in the
range of z-axis covered.
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would be unethical to exclude these structures from inter-
pretation and therefore a second reconstruction of the images
on mediastinal and lung windows at full field of view to
allow the same breadth of visualisation as a regular chest CT
should be performed routinely in every case. These images
should be reviewed by a radiologist to provide the opportu-
nity for an alternative diagnosis that may account for the
patient’s symptoms or detect important but clinically occult
problems such as early stage lung cancer.
Standards for the Performance of CCT
CT facility requirements
For diagnostic-quality CCT, a CT scanner should meet or
exceed the following specifications:
1. For contrast-enhanced CCTA a scanner must be capable
of achieving in-plane resolution of less than 0.5  0.5
mm axial, z-axis spatial resolution of less than 1 mm
longitudinal, and temporal resolution of less than 0.25
seconds.
2. Tube heat capacity that allows for a single acquisition
greater than 20 seconds.
3. All active CT facilities must have dose-reduction strat-
egies in place. This should include but not be limited to
ECG dose modulation and specific protocols for smaller
patients. Ideally, laboratories also should have the ability
to acquire data with prospective gating or step-and-shoot
sequential axial scanning.
4. Minimum section thickness no greater than 3 mm for
calcium score CT and no greater than 1.5 mm for CT
angiography [179].
To allow for adequate contrast-enhanced CCT, a power
injector capable of delivering a programed volume of
a contrast agent at a steady flow rate of at least 4 mL/s for
a delivery of greater than 300 mg/mL of iodine is necessary.
The precise optimal concentration of the contrast to be used
is controversial. A dual-chambered power injector is
a requirement for adequate coronary artery visualization and
for other noncoronary CT applications [180].
Workstation capabilities must allow the interpreting
physician to perform all of the necessary postprocessing and
data manipulation to ensure a thorough interpretation. These
should include, but not be limited to, multiplanar reformats,
advanced vessel analysis, and volume rendering.
Patient preparation
Because CCTA should not be performed in patients with
an irregular heart beat such as atrial fibrillation, an ECG
should be available or obtained before the scan. Contrast
injection rates will vary between 4 and 8 mL/s, and therefore
patients should have an 18-gauge catheter or larger inserted,
preferably in a cubital vein. Because most CCTA examina-
tions will be performed on 64-detector CT scanners, heart
rate control is imperative to obtain diagnostic-qualityexaminations and to reduce radiation dose. A heart rate of 65
beats or less per minute is desirable for all patients. Physi-
cians should be familiar with the dosage and administration
of oral and intravenous b-blockers and calcium channel
blockers as well as with contraindications to their use and
their side effects. Physicians also should be familiar with the
treatment of adverse reactions to these medications.
All patients undergoing CCT ideally should receive oral
nitrates immediately before image acquisition. Physicians
should be aware of the contraindications to their use and the
treatment of adverse reactions if they occur [2,181].
Radiation control
As in all imaging, care always must be taken to ensure
the patient receives the lowest radiation dose possible. The
policy of As Low As Reasonably Acceptable (ALARA)
must be at the very heart of any coronary CT facility. The
director or interpreting physician must be familiar with all
of the recent dose-reduction strategies [182, 183]. Prospec-
tive gating, or so-called step-and-shoot axial scanning,
should be considered when it could answer the clinical
question adequately. The decision to use such techniques
should be made with an understanding of its limitations such
as the lack of functional data and the inability to scan
patients with significant variability in heart rate. Other steps
to limit patient dose including the use of breast shields,
individualized kVp selection, and limits on z-axis coverage
should be implemented [184]. Substantial dose savings can
and should be realized by lowering the tube voltage from the
routine 120 kV to 100 kV or 80 kV [185]. This also results
in increases in the level of vascular attenuation. Pooled
experience would suggest that in patients with a body mass
index less than 25 that 100 kV can be used routinely with
more than satisfactory results. Similarly, low kV scanning
should be used when performing CCT in adolescent and
pediatric patients for suspicion of coronary anomalies and
other congenital cardiovascular conditions [186]. Dose
modulation should be used routinely, except when planning
on evaluating valve disease in systole, which should be
undertaken when other techniques already have been
considered.
Reporting standards
Structured and complete reporting are key elements for
a functioning and valuable service in all areas of medical
imaging. Never is this truer than in coronary CT angiography.
Although formal reporting standards are not being proposed,
there are a number of recommendations that should be
considered.
1. Patient data: demographics, indications, diagnosis,
background data (Framingham risk assessment), relevant
clinical history, and consent.
2. Technical data: medications administered for rate control
and coronary dilatation, acquisition parameters, recon-
struction techniques, vitals, and complications. The
technical component of the report should refer to the type
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contrast material used, both the type and volume.
3. Results: The first statement in the results component of
a report should refer to the quality of the study. This
includes an overview statement and some explanation for
limitations or artifacts that were encountered. After the
technical quality of the study is stated, the report should
consist of a formal evaluation of noncardiac, cardiac but
noncoronary, and coronary findings.
Noncoronary cardiac findings should include a review of
the great vessels, myocardium, cardiac chambers, pericar-
dium, and valvular disease. Data regarding function and
valve assessment would be limited to helical retrospective
acquisitions.
Coronary assessment should include but not be limited to
a review of dominance including a descriptor of course and
branching patterns. There also should be an overview state-
ment regarding the presence or absence of plaque burden and
the type of plaque. For the reporting of stenosis, use of the
American Heart Association classification is recommended
but is not believed to be a requirement [185]. Consistent and
accurate vessel labeling and description is of utmost impor-
tance. Common terminology used in conventional angiog-
raphy reports describing lesions as proximal, mid, and distal
according to the main coronary and branch anatomy should
be used. Vessel size and distribution of various coronary
segments is important to help guide clinical decision making.
In addition, Agatston or mass calcium scores should be
reported when formal calcium scanning is undertaken.
Stenosis evaluation and visual quantification should be
performed in all coronary CT angiograms when plaque is
present. Although the strength of coronary CT angiography is
in the exclusion of disease in patients with low pretest
probability [49,52], attempts should be made to quantify
stenosis, understanding the limitations of stenosis grading in
CT caused by limitations in spatial resolution. Quantitative
CCTA is not required but a consistent grading scale should
be used. A quartile system or a 5-point grading scale [187] is
recommended to help guide the referring physician regarding
the need for further noninvasive testing or invasive angiog-
raphy. Stenosis descriptors also should include comments
regarding vascular remodelling and plaque density when
possible. All CT angiography facilities should pursue
conventional angiographic follow-up evaluation when avail-
able to assess internal accuracy.
Training and continuing medical education requirements
The training and continuing medical education require-
ments for the performance of CCT are difficult and contro-
versial issues. Because CCT currently is being performed by
both radiologists and cardiologists, it is important that
adequate training take place in both subspecialties. It also is
important that both subspecialties work in a collaborative
environment. For these reasons, the Canadian Association of
Radiologists and the Canadian Cardiovascular Society are
exploring the possibility of developing training standards forradiologists and cardiologists that would be acceptable to
both societies as part of a larger collaborative document on
CCT. The training requirements will apply to a scope of CCT
practice that includes the contrast-enhanced evaluation of
cardiac chambers, coronary vessels and coronary bypass
grafts, and the nonenhanced evaluation of coronary calcium.
These requirements will not include approval necessary for
other vascular or thoracic imaging.
Conclusions
CCT allows a rapid noninvasive assessment of cardiac
anatomy and function. Radiologists must play a crucial role
in the education of physicians referring patients for CCT and
in the proper implementation of a CCT program within their
own institutions. The Canadian Association of Radiologists
recognizes the importance of setting appropriate standards
and guidelines for this rapidly evolving imaging technique.
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